BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 15126416)

  • 41. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
    Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
    Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
    Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
    Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
    Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
    Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model.
    Dickinson AM; Sviland L; Dunn J; Carey P; Proctor SJ
    Bone Marrow Transplant; 1991 Mar; 7(3):209-16. PubMed ID: 1829387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice.
    Nagler A; Pines M; Abadi U; Pappo O; Zeira M; Rabbani E; Engelhardt D; Ohana M; Chowdhury NR; Chowdhury JR; Ilan Y
    Hepatology; 2000 Mar; 31(3):641-8. PubMed ID: 10706554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetics of CD4+ and CD8alpha+ T-cell subsets in graft-versus-host reaction (GVHR) in ginbuna crucian carp Carassius auratus langsdorfii.
    Shibasaki Y; Toda H; Kobayashi I; Moritomo T; Nakanishi T
    Dev Comp Immunol; 2010 Oct; 34(10):1075-81. PubMed ID: 20493902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft disease.
    Hard RC; Carter WH; Bick PH
    J Immunol; 1983 Dec; 131(6):2623-9. PubMed ID: 6358351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-cell P/E-selectin ligand alpha(1,3)fucosylation is not required for graft-vs-host disease induction.
    Eom HS; Rubio MT; Means TK; Luster AD; Sykes M
    Exp Hematol; 2005 Dec; 33(12):1564-73. PubMed ID: 16338500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The influence of subclinical level of graft versus host reaction on reconstitution of host lymphoid tissues].
    Hirano M
    Hokkaido Igaku Zasshi; 1994 May; 69(3):453-65. PubMed ID: 7927174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation: association between idiopathic pneumonia syndrome and acute graft-versus-host disease.
    Liu Q; Ning J; Zhang Y; Wu X; Luo X; Fan Z
    Transpl Immunol; 2010 May; 23(1-2):12-7. PubMed ID: 20226241
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
    Takabayashi M; Kanamori H; Takasaki H; Yamaji S; Koharazawa H; Taguchi J; Tomita N; Fujimaki K; Fujisawa S; Maruta A; Ishigatsubo Y
    Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
    Ilan Y; Margalit M; Ohana M; Gotsman I; Rabbani E; Engelhardt D; Nagler A
    Hum Immunol; 2005 Mar; 66(3):231-40. PubMed ID: 15784461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-γ pathway.
    Park HB; Oh K; Garmaa N; Seo MW; Byoun OJ; Lee HY; Lee DS
    Transplantation; 2010 Oct; 90(8):825-35. PubMed ID: 20697326
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunologic induction of reticulum cell sarcoma: donor-type lymphomas in the graft-versus-host model.
    Gleichmann E; Peters K; Lattmann E; Gleichmann H
    Eur J Immunol; 1976 Jun; 5(6):406-12. PubMed ID: 10170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TNF receptor p55 controls early acute graft-versus-host disease.
    Speiser DE; Bachmann MF; Frick TW; McKall-Faienza K; Griffiths E; Pfeffer K; Mak TW; Ohashi PS
    J Immunol; 1997 Jun; 158(11):5185-90. PubMed ID: 9164935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
    J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.